Kumar Budur sold $1.5M of HRMY stock

Kumar Budur, Chief Medical Officer of Harmony Biosciences Holdings, Inc. (HRMY), sold 33,954 shares of HRMY stock worth $1.5M, per an SEC Form 4 filed Sep 9, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 4, 2026, 5 days before it was made public.

HRMY has moved -20.0% since the trade date, from $42.25 to $33.80 (Nov 12, 2026 close).